Tech

AstraZeneca’s UK COVID-19 vaccine clinical trial for children suspended due to concerns about blood clots

The UK and vaccine developers have so far resisted restrictions on their use and stated that there was no evidence of relevance.

AstraZeneca COVID-19 vaccine vial secured by many countries through a contract with the Serum Institute of India in partnership with Verity Pharma at a facility in Milton, Ontario, Wednesday, March 3, 2021.Image Credit: Pool Photo via Carlos Osorio / AP

AstraZeneca’s British Trial Coronavirus Oxford University said Tuesday that vaccination of children was suspended as global regulators rushed to assess possible associations with rare blood clots in adults. The university, which helped develop the puzzled vaccine, said the trial “has no safety concerns,” but said it was waiting for additional data from the UK Medicines and Healthcare Products Regulations, potentially with blood clots. Recognized concerns about relevance. Agency (MHRA) before resuming research.

“Parents and children must continue to attend all scheduled visits and can contact the exam site if they have any questions,” he added.

This is the latest drama that hit AstraZeneca, which has been controversial about the failure to deliver the promised dose to the European Union and the efficacy and safety profile of jabs.

MHRA analyzes real-world data from AstraZeneca deployments after cases were first reported in Norway and the European continent to see if there is a definitive link between jabs and rare forms of thrombi. Is one of the many organizations around the world to make sure.

Over the weekend, MHRA reported that of the 18 million doses given in the United Kingdom, there were 30 cases of blood clotting and 7 were fatal.

“We haven’t reached a conclusion yet and a review is currently underway,” the European Medicines Agency said Tuesday.

EU health commissioner Stella Kiriyakides later said authorities were expected to make a decision “late Wednesday,” she added, “in close contact” with the EMA.

The statement came after Marco Cavaleri, EMA’s chief vaccine strategy officer, said there was a “clear” connection in the Italian media and authorities would announce it within hours.

“In my opinion, I can say that now, it’s clear that it has something to do with vaccines,” Cavalelli told the Italian newspaper Ilmesagero in an interview. “But we still don’t know what causes this reaction.”

Both Germany and France limit the use of vaccines to older people for fear that young recipients may be at increased risk of blood clots.

The UK and vaccine developers have so far resisted restrictions on their use and stated that there was no evidence of relevance.

Adam Finn, a pediatric professor at the University of Bristol in the United Kingdom, said profits continue to outweigh risks.

“We need to know more about the people affected and we need to understand exactly how the disease happened,” he said.

“If you’re currently vaccinated with the Oxford-AstraZeneca vaccine, you’re more likely to survive if you’re vaccinated, and you can be less likely if you don’t,” he added.

AstraZeneca’s UK COVID-19 vaccine clinical trial for children suspended due to concerns about blood clots

Source link AstraZeneca’s UK COVID-19 vaccine clinical trial for children suspended due to concerns about blood clots

Related Articles

Back to top button